Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
School of Sociology, Central China Normal University, Wuhan, China.
Prostate. 2022 Feb;82(2):193-202. doi: 10.1002/pros.24258. Epub 2021 Oct 18.
Prostate cancer is the second most frequently diagnosed cancer for males worldwide, but the spatial and temporal trends of prostate cancer burden remain unknown in Asia. This study aimed to investigate the changing spatial and temporal trends of incidence, prevalence, mortality, disability-adjusted life year (DALY), and mortality-to-incidence ratio (MIR) of prostate cancer, and their association with the Socio-Demographic Index (SDI) in 48 Asian countries from 1990 to 2019.
Data were extracted from the Global Health Data Exchange query tool, covering 48 Asian countries from 1990 to 2019. The average annual percent change was calculated to evaluate temporal trends. Spatial autocorrelation analysis was used to obtain spatial patterns, and the association between SDI and prostate cancer burden was estimated using a spatial panel model.
In Asia, the age-standardized incidence and prevalence of prostate cancer increased in almost all countries, and its mortality and DALY also increased in over half of the countries. Significantly regional disparities were found in Asia, and the hot spots for incidence, prevalence, mortality, and DALY were all located in Western Asia, the hot spots of percent change also occurred in Western Asia for incidence and DALY. Furthermore, SDI had a positive association with mortality (coef = 2.51, 95% confidence interval [CI]: 2.13-2.90) and negative association with DALY (coef = -14.99, 95% CI: -20.37 to -9.60) and MIR (coef = -0.95, 95%CI: -0.99 to -0.92).
Prostate cancer burden increased rapidly throughout Asia and substantial disparities had persisted between countries. Geographically targeted interventions are needed to reduce the prostate cancer burden throughout Asia and in specific countries.
前列腺癌是全球男性第二大常见癌症,但亚洲前列腺癌负担的时空趋势仍不清楚。本研究旨在调查 1990 年至 2019 年期间,48 个亚洲国家前列腺癌发病率、患病率、死亡率、伤残调整生命年(DALY)和死亡率与发病率比(MIR)的变化趋势及其与社会人口指数(SDI)的关系。
数据从全球卫生数据交换查询工具中提取,涵盖 1990 年至 2019 年期间的 48 个亚洲国家。计算平均年变化率以评估时间趋势。使用空间自相关分析获取空间模式,并使用空间面板模型估计 SDI 与前列腺癌负担之间的关系。
在亚洲,几乎所有国家的前列腺癌标准化发病率和患病率都在增加,超过一半的国家的死亡率和 DALY 也在增加。亚洲存在显著的区域差异,发病率、患病率、死亡率和 DALY 的热点都位于西亚,发病率和 DALY 的变化率热点也位于西亚。此外,SDI 与死亡率呈正相关(系数=2.51,95%置信区间[CI]:2.13-2.90),与 DALY 呈负相关(系数=-14.99,95%CI:-20.37 至-9.60),与 MIR 呈负相关(系数=-0.95,95%CI:-0.99 至-0.92)。
亚洲各地的前列腺癌负担迅速增加,各国之间仍然存在巨大差距。需要针对特定国家和地区进行有针对性的地理干预,以减轻亚洲和特定国家的前列腺癌负担。